1832 Asset Management L.P. Lexaria Bioscience Corp. Transaction History

1832 Asset Management L.P.

  • $55.8 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 13, 2023
BUY
$0.72 - $1.11 $1,933 - $2,981
2,686 New
2,686 $2,000
Q4 2022

Feb 14, 2023
BUY
$1.95 - $2.98 $5,237 - $8,004
2,686 New
2,686 $6,000
Q2 2022

Aug 15, 2022
SELL
$1.88 - $4.06 $5,049 - $10,905
-2,686 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$2.78 - $4.7 $7,467 - $12,624
2,686 New
2,686 $9,000

Others Institutions Holding LEXX

# of Institutions
27
Shares Held
1.06M
Call Options Held
0
Put Options Held
0
View Full List

About Lexaria Bioscience Corp.

LEXX Quotes by TradingView
  • Ticker LEXX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,951,000
  • Market Cap $13.7M
  • Description
  • Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...
More about LEXX
Track This Portfolio

Track 1832 Asset Management L.P. Portfolio

Follow 1832 Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 1832 Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on 1832 Asset Management L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email